Why Progenics Shares Are Getting Crushed
Progenics Pharmaceuticals shares dropped on Thursday after the company announced late-stage results from its prostate cancer study.
Progenics Pharmaceuticals shares dropped on Thursday after the company announced late-stage results from its prostate cancer study.
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected big oil stocks decreased.
The August 31 short interest data have been compared with the previous report. Short interest moves in these selected social media stocks were mixed for this settlement date.
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The August 31 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks increased.
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected cybersecurity stocks increased.
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected big bank stocks decreased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data have been compared with the previous report, and short interest in most of the…
Wednesday was a mixed day for the broad U.S. markets. Crude oil made a big move in the session and reached back above $70. The S&P 500 sectors were mostly positive.
NIO entered the market relatively quietly in its initial public offering. This company is a direct competitor of Tesla in the electric vehicle market.
Kroger is scheduled to release its most recent quarterly results before the markets open on Thursday.
The FDA is cracking down on smoking, but not what is traditionally considered smoking. The agency is going after e-cigarette manufacturers, as teen smokers (vapers) have reached epidemic levels.
Vital Thearpies shares were absolutely crushed on Wednesday after the company announced less-than-favorable results for its liver failure trial.
Gilead shares were up handily on Wednesday after the company announced that it had entered into a strategic collaboration with Precision BioSciences.
Foamix Pharmaceuticals shares were last seen up early on Wednesday after the company announced a solid performance in its late-stage trial for moderate-to-severe acne.
Tuesday was a positive day for the broad U.S. markets. Crude oil more than recovered from Monday in this session. The S&P 500 sectors were more or less split down the middle.
Endocyte filed with the SEC for a secondary offering. In most cases where a company does this, we see the stock drop. However, in this case investors are cheering Endocyte and its secondary offering.
After Francesca’s released its most recent quarterly results on Tuesday, shares dropped to their lowest level ever since the company has been public.
USA Technologies shares dropped early on Tuesday after the company announced that it will not be filing its annual report (10-K form) for its fiscal year ended June 30, 2018, by the required September…
Integrated Device Technology shares hit a multiyear high early on Tuesday after it was announced that the Japanese semiconductor firm Renesas Electronics would be acquiring it.